Advertisement

Topics

Neurology-focused Aptinyx files for IPO

15:40 EDT 12 Jun 2018 | Elsevier Business Intelligence

Aptinyx Inc. (CNS disorder drug discovery and development) filed for an initial public offering.

Original Article: Neurology-focused Aptinyx files for IPO

NEXT ARTICLE

More From BioPortfolio on "Neurology-focused Aptinyx files for IPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...